Central Bank & Trust CO Bristol Myers Squibb CO Transaction History

Central Bank & Trust CO

$718 Million
Q2 2024

A detailed history of Central Bank & Trust CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Central Bank & Trust CO holds 1,589 shares of BMY stock, worth $85,742. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,589

Previous 6,572 75.82%

Holding current value

$85,742

Previous $356,000 81.74%

% of portfolio

0.01%

Previous 0.05%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$40.25 - $52.99 $200,565 - $264,049	-4,983 Reduced 75.82%	1,589 $65,000
Q4 2023 Jan 09, 2024	SELL	$48.48 - $57.85 $74,368 - $88,741	-1,534 Reduced 18.92%	6,572 $337,000
Q3 2023 Oct 10, 2023	BUY	$57.89 - $64.73 $4,283 - $4,790	74 Added 0.92%	8,106 $470,000
Q1 2023 Apr 13, 2023	SELL	$65.71 - $74.53 $78,654 - $89,212	-1,197 Reduced 12.97%	8,032 $556,000
Q4 2022 Jan 18, 2023	BUY	$68.48 - $81.09 $4,793 - $5,676	70 Added 0.76%	9,229 $0
Q3 2022 Oct 20, 2022	SELL	$0.13 - $76.84 $600 - $354,923	-4,619 Reduced 33.52%	9,159 $651,000
Q2 2022 Jul 22, 2022	SELL	$72.62 - $79.98 $88,741 - $97,735	-1,222 Reduced 8.15%	13,778 $1.06 Million
Q1 2022 Apr 18, 2022	SELL	$61.48 - $73.72 $114,291 - $137,045	-1,859 Reduced 11.03%	15,000 $1.1 Million
Q4 2021 Jan 18, 2022	SELL	$53.63 - $62.52 $16,678 - $19,443	-311 Reduced 1.81%	16,859 $1.05 Million
Q3 2021 Oct 19, 2021	SELL	$59.17 - $69.31 $31,005 - $36,318	-524 Reduced 2.96%	17,170 $1.02 Million
Q2 2021 Jul 16, 2021	SELL	$61.91 - $67.42 $253,397 - $275,950	-4,093 Reduced 18.79%	17,694 $1.18 Million
Q1 2021 Apr 20, 2021	SELL	$59.34 - $66.74 $180,512 - $203,023	-3,042 Reduced 12.25%	21,787 $1.38 Million
Q4 2020 Jan 12, 2021	SELL	$57.74 - $65.43 $36,029 - $40,828	-624 Reduced 2.45%	24,829 $1.54 Million
Q3 2020 Oct 08, 2020	SELL	$57.43 - $63.64 $419,066 - $464,381	-7,297 Reduced 22.28%	25,453 $1.54 Million
Q2 2020 Jul 15, 2020	BUY	$54.82 - $64.09 $1.59 Million - $1.85 Million	28,929 Added 757.11%	32,750 $1.93 Million
Q1 2020 Apr 14, 2020	SELL	$46.4 - $67.43 $4,872 - $7,080	-105 Reduced 0.32%	32,205 $1.8 Million
Q1 2020 Apr 14, 2020	SELL	$46.4 - $67.43 $1.32 Million - $1.91 Million	-28,384 Reduced 88.14%	3,821 $173,000
Q4 2019 Jan 13, 2020	BUY	$49.21 - $64.19 $1.4 Million - $1.83 Million	28,489 Added 745.59%	32,310 $2.07 Million
Q2 2019 Jul 16, 2019	SELL	$44.62 - $49.34 $1,874 - $2,072	-42 Reduced 1.09%	3,821 $173,000
Q1 2019 Apr 22, 2019	SELL	$45.12 - $53.8 $5,640 - $6,725	-125 Reduced 3.13%	3,863 $184,000
Q2 2018 Jul 17, 2018	SELL	$50.53 - $62.98 $5,912 - $7,368	-117 Reduced 2.85%	3,988 $221,000
Q3 2017 Oct 13, 2017	BUY	$55.23 - $63.74 $226,719 - $261,652	4,105	4,105 $262,000

Others Institutions Holding BMY

# of Institutions

2,407

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Bank & Trust CO with notifications on news.

Account

Central Bank & Trust CO Bristol Myers Squibb CO Transaction History